Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Alzheimer’s disease therapy: a moving target — Rudy J. Castellani (2011) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Alzheimer’s disease therapy: a moving target
Shared by
George Perry
Alzheimer’s disease therapy: a moving target
Article
2011
en
Authors
RC
Rudy J. Castellani
XZ
Xiongwei Zhu
George Perry
Abstract
1 min read
457 ISSN 1475-0708 10.2217/THY.11.56 © 2011 Future Medicine Ltd Therapy (2011) 8(5), 457–458 “As unlikely as it is that therapeutic approaches to Alzheimer’s disease currently under study will have any meaningful impact on disease progression, we also cannot exclude the possibility of a breakthrough in our lifetimes ... Our best hope for such a breakthrough appears to be a multimodality attack on Alzheimer’s disease biology.”
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2006
Neuropathology in Alzheimer's Disease: Awaking from a Hundred-Year-Old Dream
Akihiko Nunomura
,
Rudy J. Castellani
,
Hyoung‐gon Lee
,
Paula I. Moreira
,
Xiongwei Zhu
,
George Perry
,
Mark A. Smith
Article
2020
Role of antioxidants and a nutrient rich diet in Alzheimer's disease
Gerald Veurink
,
George Perry
,
Sandeep Kumar Singh
Article
2024
Endocrine Dyscrasia in the Etiology and Therapy of Alzheimer’s Disease
Tracy Butler
,
Sin-Ruow Tey
,
James E. Galvin
,
George Perry
,
Richard L. Bowen
,
Craig Atwood
Article
2012
Alzheimer's Disease: Advances for a New Century
George Perry
,
Xiongwei Zhu
,
Mark A. Smith
,
Aaron A. Sorensen
,
Jesús Ávila
Article
2009
Molecular Pathogenesis of Alzheimer’s Disease: Reductionist versus Expansionist Approaches
Rudy J. Castellani
,
Xiongwei Zhu
,
Hyoung‐gon Lee
,
Mark A. Smith
,
George Perry
Discussion(0)
No comments yet. Be the first to comment.